Owing to the incretin effect, analogs of GLP-1, GLP-1 receptor agonists and dipeptidyl peptidase-IV (DPP-IV) inhibitors are available as treatments for T2DM [20]. Here, DPP4 is linked to type 2 diabetes mellitus.